Crossmark

ASO Visual Abstract: Blood Group Antigen Expression in Blood and Tumor in Relation to Survival Outcomes in Resected Pancreatic Cancer, Overall and by Adjuvant Chemotherapy Regimens

Crossref DOI link: https://doi.org/10.1245/s10434-025-17519-y

Published Online: 2025-05-28

Published Print: 2025-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Inoue, Yosuke

Takamatsu, Manabu

Masugi, Yohei

Suzuki, Tatsunori

Hamada, Tsuyoshi https://orcid.org/0000-0002-3937-2755
Abe, Satoru

Hara, Kensuke

Kawaguchi, Yoshikuni

Kobayashi, Kosuke

Maekawa, Aya

Nakai, Yousuke

Sasahira, Naoki

Takeda, Tsuyoshi

Tanaka, Mariko

Uematsu, Yosuke

Uemura, Sho

Ushiku, Tetsuo

Fujishiro, Mitsuhiro

Takeuchi, Kengo

Kitago, Minoru

Hasegawa, Kiyoshi

Takahashi, Yu

,
License Information

Text and Data Mining valid from 2025-05-28

Version of Record valid from 2025-05-28
More Information

Article History

First Online: 28 May 2025

Disclosure

: Drs. Masugi and Hamada acknowledge research funding from the Daiichi Sankyo TaNeDS Funding Program. Dr. Sasahira declares Scholarship donation to institution and honararia for speakers from Taiho Pharmaceutical. Dr. Takeuchi has received consultancy fees from Nichirei Bioscience, Nippon Shinyaku, and Meiji Seika Pharma; research support from Fujirebio, SONY, and Daiichi Sankyo; honoraria from Eli Lilly, Chugai, Kyowa Kirin, and Janssen; and royalties from Sysmex, AMOY, and Nichirei bioscience. This work was not funded by any of these companies. No other conflicts of interest exist. The remaining authors have no conflicts of interest.

Document is current

Any future updates will be listed below